ClassID:

92635

C07C225/10 - CPC Classification

Classification description:

Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings with doubly-bound oxygen atoms bound to carbon atoms not being part of rings

Recent Application in this class:
#1
20260138955
2026-05-21

METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN

#2
20240417368
2024-12-19

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

#3
20230331683
2023-10-19

INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY

#4
20220340533
2022-10-27

METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED AMPK PROTEIN

#5
20220213023
2022-07-07

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

#6
20210387940
2021-12-16

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

#7
20210206727
2021-07-08

DETERRENTS FOR ARTHROPODS AND MARINE ORGANISMS

#8
20210017332
2021-01-21

Isomer-enriched 3-caranlactams and polyamides based thereon with high optical purity and adjustable crystallinity for high-performance applications

#9
20190292156
2019-09-26

Deterrents for arthropods and marine organisms

#10
20190256852
2019-08-22

Materials and methods for rapid and specific detection of synthetic cathinones

#11
20190256455
2019-08-22

Water-soluble UV-absorbing compounds and uses thereof

#12
20190023709
2019-01-24

SHIP1 MODULATORS AND METHODS RELATED THERETO

#13
20170369420
2017-12-28

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

#14
20170253596
2017-09-07

SHIP1 MODULATORS AND METHODS RELATED THERETO

#15
20170158611
2017-06-08

Water-soluble UV-absorbing compounds and uses thereof

#16
20170057909
2017-03-02

Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof

#17
20160311757
2016-10-27

Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion

#18
20160200727
2016-07-14

Process for the preparation of key intermediates of omarigliptin

#19
20160083387
2016-03-24

SHIP1 modulators and methods related thereto

#20
20150094457
2015-04-02

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#21
20150080472
2015-03-19

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#22
20140296575
2014-10-02

Multi-branched mannich base corrosion inhibitor and preparation method thereof

#23
20140170216
2014-06-19

BUPROPION HYDROBROMIDE POLYMORPHS

#24
20130210918
2013-08-15

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#25
20130059005
2013-03-07

Bupropion hydrobromide polymorphs

#26
20130030160
2013-01-31

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#27
20120309713
2012-12-06

N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses

#28
20110288279
2011-11-24

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#29
20110124880
2011-05-26

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#30
20110118501
2011-05-19

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#31
20110118451
2011-05-19

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#32
20110021562
2011-01-27

TREATMENT OF FRIEDREICH'S ATAXIA USING HISTONE DEACETYLASE INHIBITORS

#33
20100120686
2010-05-13

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#34
20100075950
2010-03-25

PHENYLPROPANONE MODULATORS OF DOPAMINE RECEPTOR

#35
20100068270
2010-03-18

Bupropion hydrobromide polymorphs

#36
20090123968
2009-05-14

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#37
20090111147
2009-04-30

Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides

#38
20080268519
2008-10-30

Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides

#39
20080268518
2008-10-30

Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides

#40
20080213840
2008-09-04

Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides

#41
20080182969
2008-07-31

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#42
20080182968
2008-07-31

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#43
20080177038
2008-07-24

Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides

#44
20080177027
2008-07-24

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#45
20080153979
2008-06-26

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

#46
20070219244
2007-09-20

Histone deacetylase inhibitors as therapeutics for neurological diseases

#47
20060217532
2006-09-28

Derivatization of non-natural amino acids and polypeptides

#48
20060217289
2006-09-28

Therapies using non-natural amino acids and polypeptides

#49
20060194256
2006-08-31

Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides